MEDICAL DEVICES SECTOR BUSINESS PROCESS MANAGEMENT MATURITY (BPMM) ASSESSMENT. Friday, November 15, 2013
|
|
- Geoffrey Bradley
- 6 years ago
- Views:
Transcription
1 MEDICAL DEVICES SECTOR BUSINESS PROCESS MANAGEMENT MATURITY (BPMM) ASSESSMENT Presented at Business Building Capability conference Las Vegas, NV Nov 11-15, 2013, Ph.D Vice Executive President -Medical Devices Sector Saudi Food Drug Authority Saudi Arabia Friday, November 15, 2013 Dr. Saleh S. AlTayyar
2 Content Introduction BPM Maturity Model Levels BPMM assessment steps Results and Development Plan
3 Introduction Ø ü ü Saudi Food and Drug Authority (SFDA) was established under the Council of Ministers resolution no (1) dated March here was no regulations for medical devices. Saudi Arabia was an open market for various manufactures from all over the world.
4 Introduction (cont) Ø ü ü ü ü Medical devices Sector (MDS) Journey to establish Medical Devices regulations and control the Saudi Medical Devices market was enhanced by: Government support Available resources Strong IT Qualified Staff
5 Introduction (cont) This led to the establishment of a state of the art MDS with: Ø Ø Mature and comprehensive medical devices regulation in harmony with GHTF guidance. Adopt strong e-solutions that allow stakeholders to communicate with MDS via internet in speedy and efficient way.
6 Introduction (cont) Ø Recruit a highly committed specialized staff in various areas of regulatory affairs (252 staff) Ø Transfer Saudi Arabian Medical Devices market from an open and non-regulated market to a well regulated one in a relatively short time.
7 Introduction (cont) This could not have happened without A well documented and managed Business Processes that govern regulations of medical devices through out the stages of their life cycle.
8 Medical Devices Life Cycle Pre-market On-market Post-market
9 SFDA Medical Device Regulations Interim Regulation National Provisions Force Of Law Implementing Rules Guidance Documents Announcements
10 Dr. Saleh S. AlTayyar
11 Dr. Saleh S. AlTayyar
12 Dr. Saleh S. AlTayyar
13 MDEL ECP IMPORTER DISTRBUTER AR Local Manuf. E- SERVICES FSN Market Authorization E. License Insp. Report MDNR Number OUTPUTS International Bodies NCMDR IMPORTER DISTRBUTER AR Local Manuf. Health Provider MDMA AR Local Manuf. MDEL IMPORTER DISTRBUTER AR MDNR IMPORTER DISTRBUTER AR Local Manuf. E- SERVICES
14 Area of responselities of Assistant VP for Admin affairs Area of responselities of Assistant VP for operations Vice President Assistant VP manager Executive manager Division head Organization Structure for Medical Devices Sector Sector Relation Office (liaison with shared/corporate core functions) International relations and business support office VP Medical Devices Sector quality control Department National Center for Medical Devices Information (NCMDI) Scientific Advisory Committees Strategy & Planning Asst. VP for Admin Affairs Asst. VP for Operations Business support unit and archiving Executive Management of Medical Devices laboratories Executive Management for Communication & Awareness Executive Management for Pre-market Approval & Scientific Evaluation Executive Management for Registration & Licensing Executive Management for Compliance & Enforcement Executive Management for Surveillance & Biometrics Center of Radiation Safety and Protection Directorate of Consumer Awareness Directorate of Quality & Risk Management Directorate of Establishment Licensing Directorate of Port of Entries Directorate of Medical Devices Surveillance Directorate of Radiation Safety & Protection Division of Awareness Division of Complaints Directorate of Industry professionals awareness & technical support Division of Complaints Directorate of Healthcare providers support Division of awareness Division of Quality Management Division Of Risk Management Directorate of Standards & Guidelines Division of Standards Division of Guidelines Division of Advertising Directorate of Medical Devices Scientific Evaluation Division of Devices Classification Division of Clinical Trials Division of Importer and Distributer Licensing Division of Manufacturers & Authorized Representatives Licensing MDNR Directorate of Medical Devices Registration Division of Clinical Trails Approvals Division of MD Registration Division of IVD Registration Directorate of Enforcement Division of Enforcement Division of Follow - Up Directorate of Compliance Assessment Division of Medical Devices Compliance Assessment Division of IVD Compliance Assessment Division of Establishments Compliance Assessment Directorate of Inspection Division of Collecting & Published Division of Follow-up & Communication Directorate of Reporting & Crisis Management Division of Incident Investigations Division of Risk & Crisis Management Directorate of Auditory & Biometrics Division of Auditory Division of Biometrics Division of radiological devices usage assessment Division of Radiation Quality Control Division of Radiation Safety & Protection Standards Division of Operation Requirements Division Directorate of Radiological Devices Surveillance Division of Radiological Devices Risk Assessment Division of Radiological Devices Measurements & Calibration Division of Radiological Devices Programs Division of Complaints Directorate of Publication Division of New Technology Assessment Division of Performance Evaluation Directorate of Marketing Authorization Division of Scientific &Technical Auditing Division of Scientific &Technical Evaluation Division of Advertising Approval Directorate of Non-MD Licensing Division of Non-IVD Licensing Division of Chemical & Distillation Licensing Division of Documents Revision Division of Medical Devices Inspection Division of IVD Inspection Division of Establishment Inspection Division of Special Access Products Dr. Saleh S. AlTayyar
15 BPM Maturity Model Levels
16 BPM Maturity Model Levels Initial Managed Unit process discipline Basic project and process management Individual process flow Individual planning Standardized Standardized methodology BPM competence center Predictable Optimizing Focus on process improvement Integrated Processes Processes are measured and controlled
17 BPMM Assessment Objective: BPMM assessments aim to assist the SFDA Medical Devices Sector in evaluating, tracking, crafting and forecasting its journey towards a more mature process centric operation. The main objectives are: Ø Understand the quality of process management currently in effect in the SFDA Medical Devices Sector.
18 BPMM Assessment (Cont) Ø Ø Ø Ø Increase the shared understanding of BPM concepts and practices across the Medical Devices Sector. Determine the current and target levels of BPM Maturity. Understand the best way to achieve the target levels. Develop a roadmap of initiatives and projects to achieve the target levels of BPM maturity over an appropriate timescale.
19 BPMM Assessment (Cont) Assessment Steps
20 BPMM Assessment (Cont) I. Kickoff Meeting Ø MD Sector BPMM started in March, 2013 by External Auditor (Leonardo Consulting) Ø Introductory and kickoff meeting was conducted with processes owners, participants and stakeholders to: ü Explain the BPMM and its levels. ü Inform all survey participants about the survey date, time and explain the survey methodology.
21 BPMM Assessment (Cont) II. Survey Ø The Survey was developed by BPTrends Associate (a global pioneer and a leader in business process management, methodology and practice) The sample included Ø Purpose: departments managers. processes owners. processes stakeholders. ü measure the MDS maturity in managing processes. ü Collect informed opinions of people inside the organization about their personal experiences.
22 BPMM Assessment (Cont) The survey was divided into two major areas: Ø ü ü ü ü ü ü Enterprise level: The activities Focused on: Strategy Process architecture Performance Alignment Governance Support
23 BPMM Assessment (Cont) Ø ü ü ü ü Process level: The sub topics canvassed by the survey was: Business processes defined Measures & managers Redesign Improvement
24 BPMM Assessment (Cont) Ø Survey quality validate: a group of processes experts were selected to compare their response with all other responses. The following was done to validate the survey s data: ü Distribution of answers across the sample for each question. ü Compare general responses against reference group. ü Reasonableness check (unusual patterns).
25 BPMM Assessment (Cont) III. Interviews Ø Interviews were conducted with all processes owners. They allow more extensive and experiential discussions about the practical application of BPM approaches and give practical insights about current effectiveness, and future challenges, for process based management.
26 BPMM Assessment (Cont) Ø Questions focused on: ü Availability of Process documents. ü Process in documents vs. in reality. ü Documented measurements and KPI tracking. ü Change management and control. ü Process improvement projects.
27 Results and Development Plan Results Target Development Plan
28 Results and Development Plan (Cont) Survey Interviews Recommended Assessment Results Target +12 months months Note: only 25% of organizations, who are taking a process approach, are at Level 4 or above. (BP trend report the state of Business Process Management 2012)
29 Results and Development Plan (Cont) 1) Staff survey reported a current BPMM of 3.0, and a 12 month target of 3.9. Based on interviews, it was assessed as ) Reference group assessment ü 2.8 for the current environment ü 3.5 for the 12 month target. 3) Adopting level 4 target is very challenging task for 12 month ü 3.5 (12 month) ü 4.0 (18 month)
30 Results and Development Plan (Cont)
31 Results and Development Plan (Cont) ENTERPRISE LEVEL Question (CURRENT) Overall Score 3.2, SD 1.02 Average (FUTURE) Overall Score 3.9, SD 0.93 Average Executive attitude Business process architecture Measures Process management Alignment BPM Center
32 Results and Development Plan (Cont) Ø The largest perceived gap is in the area of office BPM. This indicates agreement among respondents on the importance of BPM office and the need to further develop it. Ø Measures and alignment have the second largest gap. They both have the lowest score for the current environment and also need to be further developed.
33 Results and Development Plan (Cont) PROCESS LEVEL Question (CURRENT) Overall Score 2.8, SD 1.06 (FUTURE) Overall Score 3.8, SD 1.07 Average Average Business process defined Measures and managers Redesign Improvement Implementation
34 Results and Development Plan (Cont) Ø The current values are lower than those for the enterprise level. Ø All gaps are higher than those of the enterprise level. Ø The target level are consistent with the enterprise level, but the current value are generally lower.
35 Results and Development Plan (Cont) Gap Areas The following gap areas were identified:
36 Results and Development Plan (Cont) Development Plan A) Enterprise Process Architecture EPA A detail business Process Architecture model was developed to address the main three levels (i.e Strategic, medium and operational level) along with the key performance indicators KPIs for each level
37 Results and Development Plan (Cont) (EPA Level 1) M REGULATE MEDICAL DEVICES M1: Premarket M2: on Market M3: Post Market M4: Monitor and Inspect M5: Communication and Awareness M6: Quality Control First level shows the main process areas that include main functionalities.
38 Results and Development Plan (Cont) (EPA Level 2) M REGULATE MEDICAL DEVICES M1: Premarket M2: on Market M3: Post Market M1.1: Register Est. And Devices M1.2: License Est. And Devices M4: Monitor and Inspect M4.1: Inspect Establishment M4.2: Inspect Device M2.1: Clear Shipments M3.1: Manage Adverse Device Events M3.2: Resolve Adverse Device Events M5: Communication and Awareness M5.1: Increase Awareness M5.2: Manage Communication M6: Quality Control M6.1: Control Process M6.2: Manage Improvements
39 Results and Development Plan (Cont) (EPA Level 3) M1 Premarket M1.1 Register Establishment and Device M1.1.1 Register Establishment on MDNR M1.1.2 List MD in MDNR M4 Monitor and Inspect M4.1 Inspect Establishment M1.2 License Establishment and Device M1.2.1 License MD Importer and Distributer M1.2.2 License MD Authorized Representative M1.2.3 Issue Medical Devices Market Authorization M1.2.4 License Devices Ads M4.1.1 Inspect Establishment M2 On Market M2.1 Clear Shipments M2.1.1 Inspect medical Device at Ports of Entry M3 Post Market M3.1 Manage Adverse Device Events M3.1.1 Register New NCMDR User M3.1.3 Prepare Weekly Report for NCMDR M3.2 Resolve Adverse Device Events M3.2.1 Gather, add, publish international FSNs / Recalls M3.2.3 Investigate Adverse Event/Incident M4.1.2 Assess Establishment Inspection M3.1.2 Follow up and Communicate FSNs-Recalls M3.2.2 Gather, add, publish national FSNs / Recalls M4.2 Inspect Medical Device M4.2.1 Inspect Medical Device M4.2.2 Assess Medical Device Inspect M5 Communication & Awirness M5.1 Increase Awareness M5.1.1 Conduct Workshops M5.1.2 Participate in social event -conferences M5.1.3 Subscribe to the Emergency Care Research Institute (ECRI) Services M5.2.1 M5.2.1 Publish Publish material material on on M5.2 Manage MD MD Website Website Communication M5.2.3 M5.2.3 Facilitate, Develop, Publish Publish MD MD Material Material M5.2.2 Update and Maintain MD Internal web site M5.2.4 Manage Medical Devices Sector s address M6 Quality Control M6.1 Control Processes M6.2 Manage Improvements M6.1.1 Control Document M6.1.2 Conduct Internal audit M6.2.1 Improve Processes
40 Results and Development Plan (Cont) B) Measures and Governance Process owners have been appointed and every process has an owner now and every process are currently measured to evaluate performance and efficiency
41 Results and Development Plan (Cont) B) Measures and Governance (cont.) Ø Establishing Change Management (CM) Board with following responsibilities: ü Approve any change in the MD sector process architecture ü Approve any change or improvement in a process ü Approve any change in process measurements and KPIs Ø Change Management Members: ü Department executives ü MD Quality Control Department
42 Results and Development Plan (Cont) C) Process Improvement Projects A series of workshops have been conducted to Analyze and recommend identify the business processes area of improvements using Business Process Trends and Six Sigma
43 Results and Development Plan (Cont) Example: Ø Compliance and Enforcement Process: ü Process definition: Inspect, monitor and apply enforcement action to medical device establishments that violate SFDA regulations. ü Process scope: All establishments that import, export, distribute or manufacturing medical devices in Saudi Arabia
44 Results and Development Plan (Cont) Example (Cont): Ø Targets and Goals: ü Increase number of inspections. ü Decrease time needed in each case. ü Optimizing utilization of inspection. Ø Has Three Main Processes: ü Inspect Establishment. ü Assess Inspection Findings. ü Enforce Establishment.
45 Results and Development Plan (Cont) Example (Cont): Initiate Review Documents Scope and Schedule Inspect Review Findings Assess Findings Request CAP Followup Prepare Comm. meeting Make Action Prepare Enfor. Action Report Integration with Registration system Automate scheduling Auto-generate reports based on user input Time reduced: instead of search for the establishment manually Time reduced: Establishments interacts and confirm suggested visit dates. System can avoid overlapped visits for the same inspectors Time reduced: The system will generate all reports with the required format. This will save good deal of time in comparison of doing each report manually.
46 Results and Development Plan (Cont) Example (Cont): Ø Improvement Results Targets Old Process New Process # of inspections per year Time to close case * 5 Months 2-3 Months Inspector utilization 35% 95% * Time needed from case initiation to close case in assessment or enforcement stage.
47 Results and Development Plan (Cont) D) BPM Communication Plan Ø BPM monthly committee: ü SFDA BPM office. ü Medical Device sector Quality Control Department. ü Food sector Quality Control Department. ü Drug sector Quality Control Department.
48 Results and Development Plan (Cont) E) Capability Development
49 Results and Development Plan (Cont) E) Capability Development (cont.) Training Type BPM (on Methodology) Performance Measurement Six Sigma certifications Goal All staff in managerial levels All process owners All staff in quality office
50 Results and Development Plan (Cont) E) Capability Development (cont.) Training Type Goal Achieved BPM (on Methodology) Performance Measurement Six Sigma certifications All staff in managerial levels All process owners All staff in quality office 10 executives and managers All process owners One black belt certified and several green belt
51 What Help MDS Achieve this Result? Ø Ø Ø Ø Ø Establishing Quality Management System (QMS) Standard Operating Procedures Implementation s ISO9001:2008 certification Monitoring Key performance Indicators (KPIs) Improvements Projects ü Six sigma
52 What Helped MDS Achieve this Result? (Cont) Obtained ISO9001:2008 certificate
53
MDS-G25. Guidance on Requirements for Storage, Handling and Transportation of Medical Devices
MDS-G25 Guidance on Requirements for Storage, Handling and Transportation of Medical Devices Version Number: 1.0 Version Date: 10/4/2018 This guidance document has been published after being distributed
More informationDr. Nazeeh S. Alothmany Meshal A. Al-Amri. Saudi Food & Drug Authority
Dr. Nazeeh S. Alothmany Meshal A. Al-Amri Saudi Food & Drug Authority Saudi UDI expectations and barcode requirements Dr. Nazeeh S. Alothmany, Vice Executive President, Saudi Food and Drug Authority Meshal
More informationOverview of Regulatory Framework for Medical Devices & IVDs and likely Implementation Roadmap. Jane Rogers SAAPI Conference 13 April 2016
Overview of Regulatory Framework for Medical Devices & IVDs and likely Implementation Roadmap Jane Rogers SAAPI Conference 13 April 2016 Regulatory Framework for Medical Devices & IVDs HAZARDOUS SUBSTANCES
More informationMEDICAL DEVICES SECTOR
MEDICAL DEVICES SECTOR MDS - G4 GUIDANCE FOR OVERSEAS Version 2 Our mission is to ensure the safety of food. the safety, quality and efficacy of drugs. and the safety and effectiveness of medical devices,
More informationMDS - G4 GUIDANCE FOR OVERSEAS MANUFACTURERS
MDS - G4 GUIDANCE FOR OVERSEAS MANUFACTURERS Part I: Preparing for Medical Device Part II: Applying for Medical Device Marketing Authorization Part III: Activities after the Device Receives Marketing Authorization
More informationGLOBALIZATION: CHALLENGES AND SOLUTIONS
GLOBALIZATION: CHALLENGES AND SOLUTIONS Kaiser J. Aziz, Ph.D. Senior Clinical & Regulatory Affairs Consultant The FDA Group, LLC THIS PRESENTATION WILL ADDRESS THE FOLLOWING TOPICS: Overview of Globalization
More informationISO 9001:2015 Certification. What is it, why we did it, and what this means to you
ISO 9001:2015 Certification What is it, why we did it, and what this means to you What is ISO 9001:2015 ISO International Organization for Standardization worldwide federation of 162 national standards
More informationA partnership. that delivers a healthcare excellence
C O R P O R A T E P R O F I L E A partnership that delivers a healthcare excellence A Subsidiary of Established -1972 ranked #62 in Saudi Arabia is the only Saudi Distributor that is publicly listed on
More informationDisclosures. Laboratory Stakeholders. IVD vs. LDT. FDA Regulation of Laboratory Developed Tests 10/2/2015. FDA Regulation of LDTs
Disclosures FDA Regulation of Laboratory Developed Tests Beaumont Health System, 24 th Annual Symposium on Molecular Pathology September 16, 2015 Roger D. Klein, MD JD Director, Molecular Pathology Clinical
More informationCourse Title ID Duration Basic Premium. Biological Evaluation of Medical Devices: A Risk-Based Approach N mins
Pre-Clinical Basic Level : CMDA Certified Medical Device Associate Biological Evaluation of Medical Devices: A Risk-Based Approach N134 63 mins 186.00 144.00 Introduction to Process Validation N135 75
More informationGlobal Harmonization Task Force Past, Present and Future
Global Harmonization Task Force Past, Present and Future IOM Public Workshop June 15, 2010 Janet Trunzo Executive Vice President Technology and Regulatory Affairs Outline Need for Harmonization Background
More informationPrequalification of in vitro diagnostics - Technical Update 24 November 2015
Prequalification of in vitro diagnostics - Technical Update 24 November 2015 Copenhagen, Denmark 22-26 November 2015 1 Changes assessment Copenhagen, Denmark 22-26 November 2015 2 Changes to a Prequalified
More informationKorean Medical Devices Regulations
Korean Devices Regulations The Ministry of Health and Welfare (MHW) is the healthcare agency having overall responsibility for Devices. The Korea Food and Drug Administration (MFDS), an agency under MHW,
More informationEnvironmental Management Systems
Environmental Management Systems The standards to meet ISO 14001 First version 1994 Second version 2004 EMAS EMS Standards First version EMAS I: 1993 Second version EMAS II: 2001 BS 8555:2003 Also known
More informationStaffing - Medical Devices
Staffing - Medical Devices LONDON GENEVA SINGAPORE DUBLIN procorre.com 1 Implementing solutions to clients worldwide 2 Contents Services 04 Sector Overview 07 Medical Devices 07 In-Vitro Diagnostics 08
More informationUpdate on GCC Region. 8 May Prof. Saleh Bawazir Vice President for Drug Affairs Saudi Food and Drug Authority Riyadh, Saudi Arabia
Update on GCC Region ICH-GCG Meeting, Brussels 8 May 2007 Prof. Saleh Bawazir Vice President for Drug Affairs Saudi Food and Drug Authority Riyadh, Saudi Arabia 1 Three meetings were conducted since November
More informationMDSAP Me M dical D e D vice S i S ngle Audit Program
MDSAP Medical Device Single Audit Program Gary Minks VP, Quality & Regulatory Affairs TÜV SÜD America Inc. gminks@tuvam.com Revision: 2013(09(29 TÜV SÜD America 13(04(29 Slide 1 IMDRF International Medical
More informationADVANCED INTERNAL AUDIT WORKSHOP
ADVANCED INTERNAL AUDIT WORKSHOP By Paul J. Kunder RABQSA QMS Lead Auditor/Aerospace Industry Experienced Auditor RABQSA Approved Aerospace Auditor Transition Training (AATT) Trainer Vice Chair U.S. Z1A
More informationGENERAL MANAGEMENT Supply Chain Management: Initial 2 100,000 Supply Chain Management: Advanced 2 100,000 Quantitative Methods in Business 2 100,000
TRAINING PROGRAM 2018 FEES PER PARTICIPANT & IN NAIRA LEADERSHIP & EXECUTIVE MANAGEMENT Developing Leadership Competencies 2 100,000 Building and Developing Productive Executives 2 100,000 Critical Thinking
More informationSaudi FDA Drug Approval Process. Dr. Mohammed A. Alquwaizani Consultant- Chief of the scientific office Saudi Food and Drug Authority
Saudi FDA Drug Approval Process Dr. Mohammed A. Alquwaizani Consultant- Chief of the scientific office Saudi Food and Drug Authority Objective Describe the drug regulation practice in Saudi Arabia and
More informationMedical Device Regulatory Framework 9 SEPTEMBER 2015 FUNDISA CONFERENCE JANE ROGERS
Medical Device Regulatory Framework 9 SEPTEMBER 2015 FUNDISA CONFERENCE JANE ROGERS Key Topics Definitions Essential Principles Classification Conformity Assessment Framework License to Manufacture, Import,
More informationMedical Device Registration in China
www.cirs-md.com IVD Medical Device Registration in China Your Local Regulatory Affairs Staff-CIRS CIRS assist you Overseas Medical Devices In Vitro Diagnostic reagent Market access CFDA Registration Pre-market
More informationUnderstanding the landscape: a strategic approach to registration in China. David Harrison VP QA RA Asia Pacific, Alere Inc.
Understanding the landscape: a strategic approach to registration in China David Harrison VP QA RA Asia Pacific, Alere Inc. cknowledgements to: Alere Inc: Jillianne Coles Samara Zhu Brandwood Biomedical:
More informationRight-sizing SOX Frameworks with Risk Management. Chris McClean Vice President, Research Director
Right-sizing SOX Frameworks with Risk Management Chris McClean Vice President, Research Director Presenters Chris McClean Vice President, Research Director Serving Security & Risk Professionals Forrester
More informationDeputy Head of Division (IT Security and Architecture)
Deputy Head of Division (IT Security and Architecture) Reference 2015-217-EXT Type of contract Who can apply Salary Working time Place of work Closing date for applications Fixed-term contract which may
More informationQUESTIONNAIRE FOR COMPETENT AUTHORITIES TO BE USED FOR ASSESSMENT, REASSESSMENT AND SELF- EVALUATION
PHARMACEUTICAL INSPECTION CO-OPERATION SCHEME PS/W 1/2011 2 Annexes 22 July 2011 QUESTIONNAIRE FOR COMPETENT AUTHORITIES TO BE USED FOR ASSESSMENT, REASSESSMENT AND SELF- EVALUATION PIC/S 2011 Reproduction
More informationKEW FOUNDRIES JOURNEY TO ISO 9001:2008 CERTIFICATION..the CROWNING GLORY on HEADGEAR GLOBALLY..
KEW FOUNDRIES JOURNEY TO ISO 9001:2008 CERTIFICATION Our Customer comes first JOURNEY TO ISO 9001:2008 CERTIFICATION - CONTENTS About KEW Foundries (Kimberley Engineering Works) Why ISO 9001:2008? Implementation
More informationType Course Title Sample Content core Introduction to BPM To overview the BOK material,
BPM Model Curriculum According to the ABPMP International's Guide to The Business Process Management Common Body Of Knowledge, "Business Process Management (BPM) is a disciplined approach to identify,
More informationContents. Regulatory Bodies... 13
Contents UNITED STATES... 3 Regulatory Bodies... 3 Product Classification and Regulatory Control... 3 Application Documents... 3 Quality System Requirements... 4 Product and Manufacturer s License... 4
More informationThe Process-Centric Enterprise. Roger Tregear
The Process-Centric Enterprise Roger Tregear Process Centric Enterprise 2 Process-Centric Enterprise Functional Organisation Process Organisation 3 Process-Centric Enterprise 4 Process-Centric Enterprise
More informationDavid W Feigal, Jr., MD MPH
Global Harmonization Summit Where have we been with Harmonization? David W Feigal, Jr., MD MPH Adjunct Professor, College of Law, Arizona State University Partner, NDA Partners LLP September 18, 2014 Washington
More informationData Transparency and Quality Metrics
Data Transparency and Quality Metrics Ann Ferriter Division of Analysis and Program Operations Office of Compliance Center for Devices and Radiological Health Why are we interested in transparency? What
More informationMonterey County WEIGHTS AND MEASURES INSPECTOR I
Monterey County 30G20 WEIGHTS AND MEASURES INSPECTOR I DEFINITION Under immediate supervision, receives training and performs limited inspections and tests to enforce Division 5 of the California Business
More informationCDRH s Inspection Strategy for 2018: How it Will Impact Your Company
CDRH s Inspection Strategy for 2018: How it Will Impact Your Company CAPT Sean M. Boyd, MPH, USPHS Deputy Director for Regulatory Affairs CDRH Office of Compliance Patients are at the Heart of What We
More informationProgram Management Procedure. Quality Management System
LACCD Bond Program Program Management Procedure Quality Management System Procedure Number: PM 9.0 Effective Date: Total Pages: 10 Controlled Document No.: SharePoint Copy 1.0 Purpose Quality is an integral
More informationOversight of Laboratory Developed Tests
Oversight of Laboratory Developed Tests APHL Annual Meeting 2015 Indianapolis Alberto Gutierrez, PhD Office of In Vitro Diagnostics and Radiological Health 1 Overview Background IVD regulation Need for
More informationMedical Device Regulatory Roadmap SAMED Conference 2-3 December 2015
Medical Device Regulatory Roadmap SAMED Conference 2-3 December 2015 Dr J. Gouws Registrar of Medicines Status in RSA: 2 December 2015 Legislation: Bill 6D, 2014 Defines MD and IVDs Licensing of Manufacturers,
More informationMedical Device Regulatory Roadmap SAMED Conference 2-3 December 2015
Medical Device Regulatory Roadmap SAMED Conference 2-3 December 2015 Dr J. Gouws Registrar of Medicines Overview Global status on MD and IVDs National status on MD and IVDs Legislation Key player and Responsibilities
More informationUnited States Department of Agriculture Food Safety and Inspection Service. Public Health Information System (PHIS)
Public Health Information System (PHIS) 1 PHIS Overview Bill Smith, Assistant Administrator Office of Program Evaluation, Enforcement and Review 2 FSIS Inspection and Data Infrastructure Improvements OIG
More informationSaudi Food & Drug Authority. Khaled Ali Aldahami D.V.M; MSc Head of foreign establishments inspection section
Saudi Food & Drug Authority Khaled Ali Aldahami D.V.M; MSc Head of foreign establishments inspection section KINGDOM OF SAUDI ARABIA (KSA) Population : 32,770,375 * Capital : Riyadh Area: 2,240,000 km2
More informationPanel Discussion: European Medical Device Regulations Preparing for the Storm Moderator: Lenita Y. Sims Spears, Senior Quality Consultant/Senior
Panel Discussion: European Medical Device Regulations Preparing for the Storm Moderator: Lenita Y. Sims Spears, Senior Quality Consultant/Senior Regulatory and Compliance Counsel, BioTeknica Panelists:
More informationSUPPLY AND INSTALLATION OF TURBINES AND GENERATORS CONTRACT SCHEDULE 8 QUALITY MANAGEMENT TABLE OF CONTENTS
SUPPLY AND INSTALLATION OF TURBINES AND GENERATORS CONTRACT SCHEDULE 8 QUALITY MANAGEMENT TABLE OF CONTENTS 1 INTERPRETATION... 1 1.1 Definitions... 1 2 QUALITY MANAGEMENT SYSTEM... 2 2.1 Quality Management
More informationTrial acceptance of MDSAP audit reports in Japan
Trial acceptance of MDSAP audit reports in Japan Pharmaceuticals and Medical Devices Agency (PMDA), Office of Manufacturing / Quality and Compliance March 2018 1 Japan s participation to MDSAP International
More informationAudit of Weighing Services. Audit and Evaluation Services Final Report Canadian Grain Commission
Audit and Evaluation Services Final Report Canadian Grain Commission November 2016 Table of Contents 1. EXECUTIVE SUMMARY... 2 Conclusion... 2 Statement of Assurance... 2 2. INTRODUCTION... 3 Authority
More informationDigital Transformation Blueprint. The Dawn of the Digital Industrial
Digital Transformation Blueprint The Dawn of the Digital Industrial The age of the Industrial Internet of Things is upon us Let GE Digital help get you get started. Build your Digital Transformation Blueprint
More informationA View from the Other Side: Tales from a Compliance Liaison
A View from the Other Side: Tales from a Liaison SCCE & Ethics Institute September 27, 2016 Sahar Oswald Customer Care Manager Jeannette Woo Regulatory Affairs Manager READ AND DELETE For best results
More informationDragon1 EA Framework. Introduction in.
www.dragon1.com Introduction in Dragon1 EA Framework A set of Business Process & Enterprise Architecture Reference Models on the dragon1.com Collaboration Platform A Management Overview Revision Date:
More informationPerforming Multiple Regulatory Requirements within a Program Such as GMP, GLP, GCP, Medical Devices, and/or Controlled Substances
Performing Multiple Regulatory Requirements within a Program Such as GMP, GLP, GCP, Medical Devices, and/or Controlled Substances Performing Multiple Regulatory Requirements within a Program Such as GMP,
More informationMonitoring Quality Making Sure You Are a Top Notch Operation
Monitoring Quality Making Sure You Are a Top Notch Operation Presented to: Healthcare Call Center Times Conference, June 2017 Presented by: Gina Minas RN, MHA Six Sigma Yellow Belt Certified in Call Center
More informationDIRECTOR, MARKETING AND COMMUNICATION
DIRECTOR, MARKETING AND COMMUNICATION Board Approved March 25, 2015 FLSA: EXEMPT DEFINITION Under general direction of the President, plans, organizes, manages, and provides administrative direction and
More informationThe EPA Business need for LEMA. Tom Stafford
The EPA Business need for LEMA Tom Stafford Conceptual Holistic View LEMA Third Parties Inspectors Admin Staff Monitoring Staff Internet EDMS New IT System Management Extranet EEN Statutory
More informationHealth Canada Enforcement of Consumer Products
September 27, 2016 Vietnam Buyers Training Health Canada Enforcement of Consumer Products Jerry Wu Regional Manager, Consumer Product Safety Health Canada OVERVIEW Monitoring the Marketplace Inspections
More informationMed-Info. Introduction to Korean medical device regulations. TÜV SÜD Product Service GmbH
Med-Info International expert information for the medical device industry Introduction to Korean medical device regulations The Ministry of Food and Drug Safety (MFDS) is the healthcare agency having overall
More informationFDA Initiatives and Regulatory Trends for Life Sciences. Larry Spears President L. Spears Consulting
FDA Initiatives and Regulatory Trends for Life Sciences Larry Spears President L. Spears Consulting Before We Begin If you experience technical problems, please contact GoToMeeting Technical Support at
More informationEXPORTER AND IMPORTER GUIDELINES KSA CAP EXPORTER AND IMPORTER GUIDELINES
INTRODUCTION Mandatory standards in the Kingdom of Saudi Arabia (KSA) are applied equally to both imported and domestically produced products for the protection of health, safety, national security, public
More informationSoftware AG TechEd 2015 User Conference
Software AG TechEd 2015 User Conference ARIS News & Roadmap Georg Simon SVP Product Marketing April 2015 1 1 2 3 4 5 Unlocking the power of Social Collaboration Better Processes Today with ARIS Cloud Connect
More informationBoard & Superintendent
Board & Superintendent Roles & Responsibilities 1111 W. 9th St. Juneau, AK 99801 (907) 463-1660 phone (907) 586-2995 fax General FuNctions Governs the district; hires the superintendent, establishes expectations,
More informationOFFICERS ROLES, RESPONSIBILITIES, SKILLS AND SELECTION GUIDE
BACKGROUND Real success of execution lies in detail, and this document serves to provide detailed roles, responsibilities, skills and selection guide. POLICY STATEMENT The chapter shall establish, maintain,
More informationSTATEMENT OF STEVEN GUTMAN, M.D., DIRECTOR
DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration Rockville MD 20857 STATEMENT OF STEVEN GUTMAN, M.D., DIRECTOR OFFICE OF IN VITRO DIAGNOSTIC DEVICE EVALUATION AND
More informationENVIRONMENTAL COMPLIANCE PROGRAM COORDINATOR
ENVIRONMENTAL COMPLIANCE PROGRAM COORDINATOR Class specifications are intended to present a descriptive list of the range of duties performed by employees in the class. Specifications are not intended
More informationSECTION L QUALITY ASSURANCE. 1) designating and managing quality control functions, including:
NT-L1.000 QUALITY ASSURANCE PROGRAM All NADOs shall have a QA Program. Current (2 nd Edition) NT-L1.100 BASIC ELEMENTS SECTION L QUALITY ASSURANCE The QA program shall include, at a minimum: 1) designating
More informationQuality Management System Guidance. Transition Planning Guidance
Quality Management System Guidance Table of Contents 1 Transitioning to ISO 9001:2015... 2 Process Approach... 3 Context of the Organization... 3 Scope of the Quality Management System... 4 Leadership...
More informationCustomer-focused review of the IT services formerly provided by Health Solutions Wales (now provided by NWIS) Velindre NHS Trust
Customer-focused review of the IT services formerly provided by Health Solutions Wales (now provided by NWIS) Velindre NHS Trust Audit year: 2010-11 Issued: February 2012 Document reference: 161A2012 Status
More informationSFDA Pharmacovigilance System Explained
مركز د. صالح عبدهللا باوزير لإلستشارات الصيدالنية Prof.BawazirPharmaConsultingCenter() SFDA Pharmacovigilance System Explained Dates of The Training 9-12 October 2017 RIYADH, SAUDI ARABIA KEY TOPICS OVERVIEW
More informationMARKETING AND COMMUNICATIONS ANALYST I Limited Term
Regular Recruitment No.: 18.156 Date Opened: 5/1/2018 MARKETING AND COMMUNICATIONS ANALYST I Limited Term SALARY: FINAL FILING DATE: $25.92 to $36.47 Hourly (26 pay periods annually) We are accepting the
More informationCLIA Challenges in Laboratory Consolidation
CLIA Challenges in Laboratory Consolidation 5/1/18 Kandice Kottke-Marchant, MD, PhD Pathology & Laboratory Medicine Institute Eileen Pomiecko, HACP, CJCP Senior Director Regulatory Affairs Cleveland Clinic
More informationHOT TOPICS IN PV. Establishing a good Pharmacovigilance system: Essential elements 2 January 2014 Petach Tikva
HOT TOPICS IN PV International Society of Pharmacovigilance Establishing a good Pharmacovigilance system: Essential elements 2 January 2014 Petach Tikva Dr Irene FERMONT, MD, MSc, EUQPPV ISOP ISRAEL Coordinator
More informationFood Safety: Hong Kong s Experience
Food Safety: Hong Kong s Experience Clement Leung Hong Kong Commissioner to the United States The Brookings Institution April 28, 2016 1 Food Safety: Hong Kong s Experience Overview of Hong Kong s food
More informationTuesday, 21 October Jang Yong Choi
Tuesday, 21 October 2014 Jang Yong Choi Contents Status of Medical Device Industry in Korea MFDS Organization and Responsibilities Medical Device Regulation Overview Medical Device Regulation Updates I.
More informationNew EU Regulation on medical devices
New EU Regulation on medical devices Summary of key changes and challenges for implementation Adrian Bartlett Medical Devices, EU Policy Manager Nickie Colson Policy Advisor, EU & International Team Content
More informationQUALITY MANUAL ECO# REVISION DATE MGR QA A 2/25/2008 R.Clement J.Haislip B 6/17/2008 T.Finneran J.Haislip
UHV SPUTTERING INC Page 1 of 18 ECO REVISION HISTORY ECO# REVISION DATE MGR QA 1001 A 2/25/2008 R.Clement J.Haislip 1017 B 6/17/2008 T.Finneran J.Haislip 1071 C 1/13/2011 R.Clement J.Haislip 1078 D 5/15/2013
More informationUPDATES ON THE ASEAN MEMBER STATES. Washington, September 2014
UPDATES ON THE ASEAN MEMBER STATES Washington, September 2014 WHERE WILL BE THE ASEAN COMMUNITY MEDICAL DEVICE SECTOR BY 2020? HOW IS IT GOING TO GIVE A BUSINESS IMPACT IN THE MEDICAL DEVICE SECTOR? Facts
More informationISO FDA QSR. ISO and FDA QSR: A Step by Step Guide to Complying with Medical Device QMS Requirements
ISO 13485 FDA QSR ISO 13485 and FDA QSR: A Step by Step Guide to Complying with Medical Device QMS Requirements Jon Speer Founder & VP of QA/RA greenlight.guru Table of Contents 1 Introduction 4 QMS Philosophy
More informationWhat is ISO/IEC 20000?
An Introduction to the International Service Management Standard By President INTERPROM September 2018 Copyright 2018 by InterProm USA. All Rights Reserved www.interpromusa.com Contents INTRODUCTION...
More informationProposed Regulatory Requirments National Health Act, Republic of South Africa CEASA Breakfast Meeting
Proposed Regulatory Requirments National Health Act, Republic of South Africa CEASA Breakfast Meeting Presented By Nonkonzo Molai, Director Health Technology Policy - National Dept of Health 20th October
More informationMEDICINES CONTROL COUNCIL
MEDICINES CONTROL COUNCIL GUIDELINE FOR A LICENCE TO MANUFACTURE, IMPORT, EXPORT OR DISTRIBUTE MEDICAL DEVICES & IVDs This guideline is intended to provide recommendations to applicants wishing to submit
More informationSaudi Drug Code (SDC), and Drug Barcoding Specifications
Drug Sector Licensing Executive Directorate Guidance for Industry Saudi Drug Code (SDC), and Drug Barcoding Specifications This document outlines the SDC and the new drug barcode requirements for pharmaceuticals.
More informationAppendix: 4.3b APPENDIX D TO THE SERVICE LEVEL AGREEMENT BETWEEN NEL CSU AND ISLINGTON CCG. SLA Performance Measures. Core Services. March 2013 (v5.
Appendix: 4.3b APPENDIX D TO THE SERVICE LEVEL AGREEMENT BETWEEN NEL CSU AND ISLINGTON CCG SLA Performance Measures Core Services March 2013 (v5.0) Overview These KPIs have been co-designed by the CSU
More informationAS&D Client Program and Audit Manual
1 Great Western Registrar LLC AS&D Client Program and Audit Manual Based on ISO 17021, AS9104, Associated ANAB Accreditation Rules & ICOP Resolutions 04/02/2018 Created and Approved by: Karey S. Yates,
More informationThe why and what of a BPMS Methodology. Salman Akhtar
The why and what of a BPMS Methodology Salman Akhtar The BPTrends Associates Pyramid Enterprise Level Business Process Level Implementation Level. Human Resource Development Job Design Training Development
More informationANDREW BALO SENIOR VICE PRESIDENT, REGULATORY, BIOMETRICS, & CLINICAL AFFAIRS DEXCOM, INC 6340 SEQUENCE DRIVE SAN DIEGO, CA 92121
DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration 10903 New Hampshire Avenue Document Control Center WO66-G609 Silver Spring, MD 20993-0002 January 23, 2015 ANDREW
More informationIn the huge expanse of Asia, Singapore and
New Medical Device Regulation 16 February 2009 By Ames Gross In the huge expanse of Asia, Singapore and Hong Kong are small places. However, after Japan, they are among the most advanced medical markets
More information2/24/2017. Analytics: Enhancing Your Hospital Compliance Program. Today s Session. Polling Question: What is Your Role in Compliance?
Analytics: Enhancing Your Hospital Compliance Program Kate Conklin, B.A., CPMSM, CPHQ, Chief Compliance Officer Trissi Gray, MBA, CHRC, Assistant Director, Health System Compliance Today s Session 1 Objective
More informationMed-Info. Introduction to Korean medical device regulations. TÜV SÜD Product Service GmbH
Med-Info International expert information for the medical device industry Introduction to Korean medical device regulations The Ministry of Food and Drug Safety () is the healthcare agency having overall
More informationQuality Manual. Wilson-Hurd Manufacturing Company. Electronic Control Products (ECP) 311 Winton Street Wausau, WI 54402
Quality Manual Wilson-Hurd Manufacturing Company Electronic Control Products (ECP) 311 Winton Street Wausau, WI 54402 Core Products (CORE) 202 S. Johnston St. Berlin, WI 54293 Rev. Date: 15 February 2017
More informationPost market Surveillance ISO EU Medical Device Regulation
Post market Surveillance ISO13485 2016 EU Medical Device Regulation Patrick Caines, Ph.D. Baxter Healthcare 15 June 2017 Agenda Post market Regulatory Requirements ISO 13485 2016 Summary of key changes
More informationVeeva 2015 Paperless TMF Survey: Annual Report
Veeva 2015 Paperless TMF Survey: Annual Report REMOVING PAPER FROM THE PROCESS The Veeva 2015 Paperless TMF Survey explores the life sciences industry s progress toward paperless clinical trials by gathering
More informationINTEGRATION OF SAFETY CULTURE INTO MANAGEMENT SYSTEM OF REGULATORY BODY
TECHNICAL MEETING ON INTEGRATION OF SAFETY CULTURE INTO REGULATORY PRACTICES AND THE REGULATORY DECISION MAKING PROCESS INTEGRATION OF SAFETY CULTURE INTO MANAGEMENT SYSTEM OF REGULATORY BODY 06 Octobre
More informationTHE CUSTOMER EXPERIENCE MANAGEMENT REPORT & RECOMMENDATIONS Customer Experience & Beyond
www.sandsiv.com THE CUSTOMER EXPERIENCE MANAGEMENT REPORT & RECOMMENDATIONS TM 1 Customer Experience & Beyond www.sandsiv.com TM Customer Experience & Beyond Legal Notice: Sandsiv 2015. All Rights Reserved.
More informationOur story. Today we serve our clients with pride, agility & compliance with the professionalism that they seek for.
COMPANY PROFILE Our story From what we experienced in the need within the Saudi & GCC market for vendors who could be a solution provider in the Pharmaceutical field, we ELMAQ team have joined up from
More informationL AGENCE GABONAISE DE NORMALISATION EXPORTER AND IMPORTER GUIDELINES GABON EXPORTER AND IMPORTER GUIDELINES
GABON INTRODUCTION The Gabonese Standard Body known as AGANOR (L AGENCE GABONAISE DE NORMALISATION), a public administrative institution of the government of Gabon, is responsible for the adoption and
More informationCode of Practice for the TL 9000 Certification Process Release 8.0
Code of Practice for the TL 9000 Certification Process Release 8.0 This document is a product of the Oversight Work Group of the TIA Business Performance Community ( BPC ). It is subject to change by the
More informationVendor Qualification Survey
1200 West 96 th St Minneapolis, MN 55431 Ph: 952-888-7900 Fax: 952-888-2719 Vendor Qualification Survey Vendor Information Company Name: Date: Address: City: Phone Number: email address: Product or Service
More informationBasics of Drug Regulatory Affairs - SFDA & GCC Explained Date Of The Training
مركز د. صالح عبدهللا باوزير لإلستشارات الصيدالنية Prof.BawazirPharmaConsultingCenter() Basics of Drug Regulatory Affairs - SFDA & GCC Explained Date Of The Training 11 July2018 Riyadh, Saudi Arabia Basics
More informationBusiness Process Management: The Right Way to Do It
Business Process Management: The Right Way to Do It Smita Sharma Introduction BPM is really all about managing processes, the people who are the doers of the process, and the systems that help them achieve
More informationYour Vision, Our Future Korean Medical Device Your Vision, Our Future
www.mfds.go.kr/eng Your Vision, Our Future Korean Korean Your Vision, Our Future 01 Passion for Growth & Excellence With a 5% average annual growth rate, the Korean medical device market was valued at
More informationValue-Added Internal Audit: Myth or Reality?
Value-Added Internal Audit: Myth or Reality? Istanbul 12 November 2013 Jean-Pierre Garitte, CIA, CCSA, CISA, CFE, RFA Past Chairman of the Board IIA Past President ECIIA Polling question #1 For how long
More informationCOCIR/MITA Joint Contribution. EU and US call for input on regulatory issues for possible future trade agreement
COCIR/MITA Joint Contribution EU and US call for input on regulatory issues for possible future trade agreement COCIR and MITA welcome the opportunity to share ideas with the United States government and
More information1.0 Determine Supplier Category (By Level)
1.0 Determine Supplier Category (By Level) When a new Supplier is selected, evaluated or re-evaluated, the SRT Chair, with support from the Purchasing Agent, will determine / confirm the Supplier Type
More informationNational laws. National Competent Authority / Authorities. Orders, ordinances (supervision)
1 The Regulatory World Only for products classified higher than class I: Notification of the body, Supervision National laws National Competent Authority / Authorities Orders, ordinances (supervision)
More information